The Current Ratio as of December 2025 (TTM) for Enzon Pharmaceuticals, Inc. (ENZN) is 55.71

According to Enzon Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 55.71. This represents a change of -18.43% compared to the average of 68.30 of the last 4 quarters.

Enzon Pharmaceuticals, Inc. (ENZN) Historical Current Ratio (quarterly & annually)

How has ENZN Current Ratio performed in the past?

The mean historical Current Ratio of Enzon Pharmaceuticals, Inc. over the last ten years is 39.29. The current 55.71 Current Ratio has changed 14.08% with respect to the historical average. Over the past ten years (40 quarters), ENZN's Current Ratio was at its highest in in the September 2021 quarter at 127.22. The Current Ratio was at its lowest in in the September 2019 quarter at 1.93.

Enzon Pharmaceuticals, Inc. (ENZN) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Enzon Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Enzon Pharmaceuticals, Inc. (ENZN) Average Current Ratio

How has ENZN Current Ratio performed in the past?

The current Current Ratio of Enzon Pharmaceuticals, Inc. (ENZN) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Enzon Pharmaceuticals, Inc. (ENZN) Current Ratio vs. Peers

How is ENZN’s Current Ratio compared to its peers?

Enzon Pharmaceuticals, Inc.’s Current Ratio is greater than Core One Labs Inc. (0.81), greater than Evolutionary Genomics, Inc. (3.92), greater than Sorrento Therapeutics, Inc. (0.29), greater than Telo Genomics Corp. (4.95), greater than Sigyn Therapeutics, Inc. (0.02), greater than Doseology Sciences Inc. (29.15), greater than Canntab Therapeutics Limited (0.57), greater than HealthLynked Corp. (0.23), greater than Futura Medical plc (2.47), greater than LFTD Partners Inc. (3.02),

Build a custom stock screener for Enzon Pharmaceuticals, Inc. (ENZN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Enzon Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Enzon Pharmaceuticals, Inc. (ENZN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Enzon Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.